Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Factors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06516939
What this trial is testing

The Application of Bovine Basic Fibroblast Growth Factor Gel in the Treatment of Sensitive Skin

Who this might be right for
Sensitive Skin
Shanghai Dermatology Hospital 28
Not applicableStudy completedNCT04640870
What this trial is testing

The Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients With Advanced EGFR Mutation-positive Non-small Cell Lung Cancer Treated With Afatinib

Who this might be right for
Non Small Cell Lung CancerEGF-R Positive Non-Small Cell Lung CancerEGFR Gene Mutation
Hellenic Cooperative Oncology Group 59
Not applicableStudy completedNCT00038675
What this trial is testing

Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate

Who this might be right for
Chronic Myelomonocytic LeukemiaChronic Myeloid LeukemiaPolycythemia Vera+2 more
M.D. Anderson Cancer Center 125
Large-scale testing (Phase 3)Looking for participantsNCT06452277
What this trial is testing

Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Who this might be right for
Advanced Non-small Cell Lung Cancer, HER2 Mutation
Bayer 555
Testing effectiveness (Phase 2)Study completedNCT01004731
What this trial is testing

Study of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody, Cetuximab, in Combination With Gemcitabine/Carboplatin in Patients With Stage IV Lung Cancer

Who this might be right for
Stage IV Non-Small Cell Lung Cancer
University of Alabama at Birmingham 7
Not applicableLooking for participantsNCT06902545
What this trial is testing

Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.

Who this might be right for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerLocally Advanced Unresectable Gastric Adenocarcinoma or CancerMetastatic Gastric Adenocarcinoma or Cancer+1 more
Astellas Pharma Korea, Inc.
Testing effectiveness (Phase 2)Study completedNCT00390845
What this trial is testing

P38 Mitogen-activated Protein (Map) Kinase Inhibitor (SB-681323)Study In Patients With Neuropathic Pain

Who this might be right for
Pain, Neuropathic
GlaxoSmithKline 50
Post-approval studies (Phase 4)WithdrawnNCT01229202
What this trial is testing

Use of Bevacizumab to Modulate the Outcomes of Trabeculectomy Surgery

Who this might be right for
Glaucoma
Nova Scotia Health Authority
Not applicableStudy completedNCT03369145
What this trial is testing

High-fat Overfeeding, Hepatokines and Appetite Regulation

Who this might be right for
Insulin ResistanceType2 Diabetes MellitusNon-Alcoholic Fatty Liver Disease+1 more
Loughborough University 12
Early research (Phase 1)Study completedNCT01233895
What this trial is testing

Study of AVE1642 Anti-IGF1R Monoclonal Antibody in Patients With Advanced Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sanofi 26
Not applicableUnknownNCT06012331
What this trial is testing

Clinical and Radiographic Evaluation of Revascularization of Immature Anterior Permanent Teeth Using Concentrated Growth Factor (CGF) Versus Blood Clot (BC)

Who this might be right for
Revascularization
Cairo University 50
Not applicableUnknownNCT04724083
What this trial is testing

Inflammatory Pathways and Cardiac Growth Factors Associated With Fabry Disease Cardiomyopathy

Who this might be right for
Fabry
Lysosomal and Rare Disorders Research and Treatment Center, Inc. 50
Testing effectiveness (Phase 2)Ended earlyNCT02753595
What this trial is testing

Study of Eribulin Mesylate in Combination With PEGylated Recombinant Human Hyaluronidase (PEGPH20) Versus Eribulin Mesylate Alone in Subjects With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, High-Hyaluronan (HA) Metastatic Breast Cancer (MBC)

Who this might be right for
Metastatic Breast Cancer
Eisai Inc. 25
Testing effectiveness (Phase 2)WithdrawnNCT00570375
What this trial is testing

The Role of Erlotinib an Epidermal Growth Factor Receptor (EGFR) Inhibitor in the Treatment of Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndrome
University of Cincinnati
Not applicableStudy completedNCT00462475
What this trial is testing

Effect of 5 Years of GH Replacement on Atherosclerosis

Who this might be right for
HypopituitarismPituitary TumorsGrowth Hormone Deficiency
Federico II University 20
Large-scale testing (Phase 3)UnknownNCT00438867
What this trial is testing

Angiogenesis in Women With Angina Pectoris Who Are Not Candidates for Revascularization

Who this might be right for
Angina Pectoris
Cardium Therapeutics 300
Testing effectiveness (Phase 2)Study completedNCT00867334
What this trial is testing

New Individualized Therapy Trial for Metastatic Colorectal Cancer

Who this might be right for
Colorectal NeoplasmColorectal Cancer
Inova Health Care Services 10
Not applicableStudy completedNCT05905939
What this trial is testing

HER2(Human Epidermal Growth Factor Receptor 2) -Positive Metastatic Breast Cancer in Russia

Who this might be right for
Breast Cancer
AstraZeneca 774
Early research (Phase 1)Ended earlyNCT01748812
What this trial is testing

Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)

Who this might be right for
Osteomalacia
National Institute of Dental and Craniofacial Research (NIDCR) 1
Testing effectiveness (Phase 2)Study completedNCT01750281
What this trial is testing

Assess Efficacy and Safety of AZD6244 in Combination With Docetaxel in Patients Receiving Second Line Non Small Cell Lung Cancer Treatment.

Who this might be right for
Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
AstraZeneca 212
Next Page
377